BioWorld Science

Nov. 4, 1998

View Archived Issues

Entropin concentrates its efforts on bringing Esterom to market

Read More

Inflazyme advances development of asthma therapeutic

Read More

Idec Pharmaceuticals: Q3 1998 highlights

Read More

Amylin: Q3 1998 highlights

Read More

Optimal dosing regimen for 5G1.1-SC in heart attack under evaluation in phase I trial

Read More

Connetics: Q3 1998 highlights

Read More

Novel isoquinoline anticonvulsants in development at SB

Read More

Korean laboratory prepares new series of TNF-alpha inhibitors

Read More

Meiji Seika discloses new neuroprotective substance isolated from fungus

Read More

Potent and selective COX-2 inhibitors from Merck Frosst useful for inflammation

Read More

New immunosuppressants in the pipeline at Kyowa Hakko

Read More

Otsuka NO inhibitor series particularly useful in asthma and atopic dermatitis

Read More

Schering-Plough describes SAR leading to discovery of potent cholesterol absorption inhibitor

Read More

Preclinical study results explain why TMK-688 does not induce drowsiness

Read More

Banyu seeks licensees for new parenteral carbapenems

Read More

Potential new antithrombotic agent profiled, structure revealed

Read More

GlyT-1 technology forms the basis of Allelix and Janssen neuropsychiatric collaboration

Read More

First Neoral equivalent cleared by FDA

Read More

New agreement between Pharmacopeia and Schering-Plough expands R&D collaboration

Read More

European research group focuses on TTD non-nucleoside reverse transcriptase inhibitors

Read More

Adoptive immunotherapy of cancer with HSPs covered by U.S. patent

Read More

Alza focuses on urology products; licenses Urispas

Read More

Medtronic seeks to become leader in neurological and spinal medical technologies

Read More

GenVec receives expanded patent coverage in field of gene therapy

Read More